|
|
细菌在肿瘤治疗中应用的研究进展
|
Abstract:
近年来，肿瘤治疗的手段不断取得新的突破，在传统的手术、化疗、放疗对肿瘤治疗存在各自局限的现状下，突破性地开发出肿瘤免疫疗法，虽然其在血液瘤、多发性骨髓瘤等治疗中取得了成功，但是对实体性肿瘤的治疗仍达不到理想效果，因此亟待新的肿瘤治疗手段的开发。细菌肿瘤疗法早有先例，但是因为其应用的安全性考量以及不能清楚阐明治疗的具体机制而未受到重视，随着生物技术的蓬勃发展，改造细菌能使其满足治疗使用的要求，越来越多关于细菌在肿瘤治疗中的应用报道。本篇综述总结了细菌在肿瘤治疗中的优势、几种常用的细菌以及细菌在肿瘤治疗中的策略，以期为开发新的肿瘤治疗手段提供理论依据和新思路。
In recent years, new breakthroughs have been made in the means of tumor treatment. Under the current situation that traditional surgery, chemotherapy and radiotherapy have their own limitations in the treatment of tumor, tumor immunotherapy has been breakthrough developed. Although it has achieved success in the treatment of hematoma and multiple myeloma, the treatment of solid tumor still fails to achieve the ideal effect. Therefore, it is urgent to develop new tumor treatment methods. Bacterial tumor therapy has a precedent for a long time, but it has not been paid attention to because of the safety considerations of its application and the failure to clearly clarify the specific mechanism of treatment. With the vigorous development of biotechnology, bacteria can be modified to meet the requirements of therapeutic use, and more and more reports on the application of bacteria in tumor therapy are reported. The article summarizes the advantages of bacteria in tumor therapy, several commonly used bacteria and the strategies of bacteria in tumor therapy, in order to provide theoretical basis and new ideas for the development of new tumor therapy.
| [1] | Kocijancic, D., Felgner, S., Frahm, M., et al. (2016) Therapy of Solid Tumors Using Probiotic Symbioflor-2—Restraints and Potential. Oncotarget, 7, 22605-22622. https://doi.org/10.18632/oncotarget.8027 |
| [2] | HoptionCann, S.A., Van Netten, J.P. and Van Netten, C. (2003) Dr William Coley and Tumour Regression: A Place in History or in the Future. Postgraduate Medical Journal, 79, 672-680. https://doi.org/10.1093/postgradmedj/79.938.672 |
| [3] | Choi, Y., Lichterman, J.N., Coughlin, L.A., et al. (2023) Immune Checkpoint Blockade Induces Gut Microbiota Translocation That Augments Extraintestinal Antitumor Immunity. Science Immunology, 8, Eabo2003. https://doi.org/10.1126/sciimmunol.abo2003 |
| [4] | Bender, M.J., McPherson, A.C., Phelps, C.M., et al. (2023) Dietary Tryptophan Metabolite Released by Intratumoral Lactobacillus reuteri Facilitates Immune Checkpoint Inhibitor Treatment. Cell, 186, 1846-1862.E26. https://doi.org/10.1016/j.cell.2023.03.011 |
| [5] | Galeano Ni？o, J.L., Wu, H., LaCourse, K.D., et al. (2022) Effect of the Intratumoral Microbiota on Spatial and Cellular Heterogeneity in Cancer. Nature, 611, 810-817. https://doi.org/10.1038/s41586-022-05435-0 |
| [6] | Fu, A., Yao, B., Dong, T., et al. (2022) Tumor-Resident Intracellular Microbiota Promotes Metastatic Colonization in Breast Cancer. Cell, 185, 1356-1372.E26. https://doi.org/10.1016/j.cell.2022.02.027 |
| [7] | Nolan, E., Bridgeman, V.L., Ombrato, L., et al. (2022) Radiation Exposure Elicits a Neutrophil-Driven Response in Healthy Lung Tissue That Enhances Metastatic Colonization. Nature Cancer, 3, 173-187. https://doi.org/10.1038/s43018-022-00336-7 |
| [8] | Zheng, J.H., Nguyen, V.H., Jiang, S.-N., et al. (2017) Two-Step Enhanced Cancer Immunotherapy with Engineered Salmonella typhimurium Secreting Heterologous Flagellin. Science Translational Medicine, 9, Eaak9537. https://doi.org/10.1126/scitranslmed.aak9537 |
| [9] | Forbes, N.S., Munn, L.L., Fukumura, D., et al. (2003) Sparse Initial Entrapment of Systemically Injected Salmonella typhimurium Leads to Heterogeneous Accumulation within Tumors. Cancer Research, 63, 5188-5193. |
| [10] | Tang, Q., Peng, X., Xu, B., et al. (2022) Current Status and Future Directions of Bacteria-Based Immunotherapy. Frontiers in Immunology, 13, Article ID: 911783. https://doi.org/10.3389/fimmu.2022.911783 |
| [11] | Leventhal, D.S., Sokolovska, A., Li, N., et al. (2020) Immunotherapy with Engineered Bacteria by Targeting the STING Pathway for Anti-Tumor Immunity. Nature Communications, 11, Article No. 2739. https://doi.org/10.1038/s41467-020-16602-0 |
| [12] | Fang, R., Jiang, Q., Jia, X., et al. (2023) ARMH3-Mediated Recruitment of PI4KB Directs Golgi-to-Endosome Trafficking and Activation of the Antiviral Effector STING. Immunity, 56, 500-515.E6. https://doi.org/10.1016/j.immuni.2023.02.004 |
| [13] | Zhang, X., Bai, X.-C. and Chen, Z.J. (2020) Structures and Mechanisms in the CGAS-STING Innate Immunity Pathway. Immunity, 53, 43-53. https://doi.org/10.1016/j.immuni.2020.05.013 |
| [14] | Yu, X., Lin, C., Yu, J., et al. (2019) Bioengineered Escherichia coli Nissle 1917 for Tumour-Targeting Therapy. Microbial Biotechnology, 13, 629-636. https://doi.org/10.1111/1751-7915.13523 |
| [15] | Behnsen, J., Deriu, E., Sassone-Corsi, M., et al. (2013) Probiotics: Properties, Examples, and Specific Applications. Cold Spring Harbor Perspectives in Medicine, 3, A010074. https://doi.org/10.1101/cshperspect.a010074 |
| [16] | Reister, M., Hoffmeier, K., Krezdorn, N., et al. (2014) Complete Genome Sequence of the Gram-Negative Probiotic Escherichia coli Strain Nissle 1917. Journal of Biotechnology, 187, 106-107. https://doi.org/10.1016/j.jbiotec.2014.07.442 |
| [17] | Clairmont, C., Lee, K.C., Pike, J., et al. (2000) Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain of Salmonella typhimurium. The Journal of Infectious Diseases, 181, 1996-2002. https://doi.org/10.1086/315497 |
| [18] | Toso, J.F., Gill, V.J., Hwu, P., et al. (2002) Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients with Metastatic Melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 20, 142-152. https://doi.org/10.1200/JCO.2002.20.1.142 |
| [19] | Zhou, D.-X., Wang, X.-H., Xu, X., et al. (2022) Anti-Tumor Effects of Engineered VNP20009-Abvec-Igκ-MPD-1 Strain in Melanoma Mice via Combining the Oncolytic Therapy and Immunotherapy. Pharmaceutics, 14, Article No. 2789. https://doi.org/10.3390/pharmaceutics14122789 |
| [20] | Pawelek, J.M., Low, K.B. and Bermudes, D. (1997) Tumor-Targeted Salmonella as a Novel Anticancer Vector. Cancer Research, 57, 4537-4544. |
| [21] | Garza-Morales, R., Rendon, B.E., Malik, M.T., et al. (2020) Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus lactis. Cancers, 12, Article No. 438. https://doi.org/10.3390/cancers12020438 |
| [22] | Feizollahzadeh, S., Khanahmad, H., Rahimmanesh, I., et al. (2016) Expression of Biologically Active Murine Interleukin-18 in Lactococcus lactis. FEMS Microbiology Letters, 363, Fnw234. https://doi.org/10.1093/femsle/fnw234 |
| [23] | Zhu, J., Ke, Y., Liu, Q., et al. (2022) Engineered Lactococcus lactis Secreting Flt3L and OX40 Ligand for in Situ Vaccination-Based Cancer Immunotherapy. Nature Communications, 13, Article No. 7466. https://doi.org/10.1038/s41467-022-35130-7 |
| [24] | Zhang, H.-Y., Man, J.-H., Liang, B., et al. (2010) Tumor-Targeted Delivery of Biologically Active TRAIL Protein. Cancer Gene Therapy, 17, 334-343. https://doi.org/10.1038/cgt.2009.76 |
| [25] | Malla, W.A., Arora, R., Khan, R.I.N., et al. (2020) Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems. Frontiers in Cell and Developmental Biology, 8, Article No. 524. https://doi.org/10.3389/fcell.2020.00524 |
| [26] | Guan, G., Zhao, M., Liu, L., et al. (2013) Salmonella typhimurium Mediated Delivery of Apoptin in Human Laryngeal Cancer. International Journal of Medical Sciences, 10, 1639-1648. https://doi.org/10.7150/ijms.6960 |
| [27] | Zhang, Y.-L., Lü, R., Chang, Z.-S., et al. (2014) Clostridium Sporogenes Delivers Interleukin-12 to Hypoxic Tumours, Producing Antitumour Activity without Significant Toxicity. Letters in Applied Microbiology, 59, 580-586. https://doi.org/10.1111/lam.12322 |
| [28] | Loeffler, M., Le’Negrate, G., Krajewska, M., et al. (2007) Attenuated Salmonella Engineered to Produce Human Cytokine LIGHT Inhibit Tumor Growth. Proceedings of the National Academy of Sciences of the United States of America, 104, 12879-12883. https://doi.org/10.1073/pnas.0701959104 |
| [29] | Savage, T.M., Vincent, R.L., Rae, S.S., et al. (2023) Chemokines Expressed by Engineered Bacteria Recruit and Orchestrate Antitumor Immunity. Science Advances, 9, Eadc9436. https://doi.org/10.1126/sciadv.adc9436 |
| [30] | Namai, F., Murakami, A., Ueda, A., et al. (2020) Construction of Genetically Modified Lactococcus lactis Producing Anti-Human-CTLA-4 Single-Chain Fragment Variable. Molecular Biotechnology, 62, 572-579. https://doi.org/10.1007/s12033-020-00274-8 |
| [31] | Gurbatri, C.R., Lia, I., Vincent, R., et al. (2020) Engineered Probiotics for Local Tumor Delivery of Checkpoint Blockade Nanobodies. Science Translational Medicine, 12, Eaax0876. https://doi.org/10.1126/scitranslmed.aax0876 |
| [32] | Vincent, R.L., Gurbatri, C.R., Li, F., et al. (2023) Probiotic-Guided CAR-T Cells for Solid Tumor Targeting. Science, 382, 211-218. https://doi.org/10.1126/science.add7034 |
| [33] | Song, P., Han, X., Li, X., et al. (2023) Bacteria Engineered with Intracellular and Extracellular Nanomaterials for Hierarchical Modulation of Antitumor Immune Responses. Materials Horizons, 10, 2927-2935. https://doi.org/10.1039/D3MH00249G |
| [34] | Wu, W., Pu, Y., Gao, S., et al. (2022) Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy. Nano-Micro Letters, 14, Article No. 220. https://doi.org/10.1007/s40820-022-00951-0 |
| [35] | Ma, X., Liang, X., Li, Y., et al. (2023) Modular-Designed Engineered Bacteria for Precision Tumor Immunotherapy via Spatiotemporal Manipulation by Magnetic Field. Nature Communications, 14, Article No. 1606. https://doi.org/10.1038/s41467-023-37225-1 |
